Clinical trials recruiting in Umhlanga, South Africa
3
Recruiting trials
8
Conditions
Phase breakdown
Phase 2 1Phase 3 1Not applicable 1
Conditions recruiting in Umhlanga, South Africa
| Condition | Trials |
|---|---|
| Chronic Kidney Disease | 1 |
| HIV | 1 |
| Heart Failure | 1 |
| Hypertension | 1 |
| Lupus | 1 |
| Pneumocystis Pneumonia | 1 |
| Systemic Lupus Erythematosus | 1 |
| Type 2 Diabetes | 1 |
Recruiting trials in Umhlanga, South Africa
- Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
- iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Common questions
How many clinical trials are recruiting in Umhlanga, South Africa?
3 recruiting trials have at least one study site in Umhlanga, South Africa.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.